Synapse - Works

Results (13841)

Long-term safety with sunitinib (SU) in metastatic renal cell carcinoma (mRCC)

Meeting Abstract

Porta, C.; Gore, M. E.; Rini, B. I.; Escudier, B.; Charles, L. P.; Chen, L.; Hariharan, S.; Motzer, R. J.
European Journal of Cancer (2013)

Fulltext@MSK | Save

Lymphatic permeation status stratifies the prognosis of pathological node positive patients with clinical stage IA lung adenocarcinoma

Meeting Abstract

Mimae, T.; Tsutani, Y.; Miyata, Y.; Yoshiya, T.; Ibuki, Y.; Nakayama, H.; Okumura, S.; Yoshimura, M.; Okada, M.
European Journal of Cancer (2013)

Fulltext@MSK | Save

Survival analysis with 5 years of follow-up in a phase III study of ipilimumab and dacarbazine in metastatic melanoma

Meeting Abstract

Maio, M.; Bondarenko, I.; Robert, C.; Thomas, L.; Garbe, C.; Testori, A.; Lu, H.; Chin, K.; Wolchok, J.
European Journal of Cancer (2013)

Fulltext@MSK | Save

The impact of young age on survival in patients with metastatic colorectal cancer: Analysis from the ARCAD Clinical Trials Program

Meeting Abstract

Lieu, C.; Renfro, L.; De Gramont, A.; Maughan, T. S.; Seymour, M. T.; Saltz, L.; Goldberg, R. M.; Sargent, D.; Eckhardt, S. G.; Eng, C.
European Journal of Cancer (2013)

Fulltext@MSK | Save

Denosumab treatment of hypercalcemia of malignancy (HCM) in patients not responding to bisphosphonate therapy

Meeting Abstract

Leboulleux, S.; Hu, M.; Glezerman, I.; Gucalp, R.; Misiorowski, W.; Jaccard, A.; Tonini, G.; Ying, W.; Braun, A.; Jain, R.
European Journal of Cancer (2013)

Fulltext@MSK | Save

Impact of doxycycline (doxy) prophylaxis on dermatologic toxicity from dacomitinib (D) for NSCLC, by CTCAE and patient (pt)-reported outcomes (PRO) measures in a placebo-controlled trial

Meeting Abstract

Lacouture, M.; Grunberg, S.; Keefe, D.; Sonis, S.; Ely, J.; Gernhardt, D.; Wang, T.; Doherty, J.; O'Connell, J.; Jatoi, A.
European Journal of Cancer (2013)

Fulltext@MSK | Save

MEDI4736, an anti-PD-L1 antibody with modified Fc domain: Preclinical evaluation and early clinical results from a phase 1 study in patients with advanced solid tumors

Meeting Abstract

Khleif, S.; Lutzky, J.; Segal, N.; Antonia, S.; Blake-Haskins, A.; Stewart, R.; Robbins, P.; Shalabi, A.; Ibrahim, R.; Wolchok, J.
European Journal of Cancer (2013)

Fulltext@MSK | Save

Evaluation of tolerability and anti-tumor activity of GDC-0032, a PI3K inhibitor with enhanced activity against PIK3CA mutant tumors, administered-to patients with advanced solid tumors

Meeting Abstract

Juric, D.; Infante, J. R.; Krop, I. E.; Kurkjian, C.; Patel, M. R.; Graham, R. A.; Wilson, T. R.; Hsu, J. Y.; Baselga, J.; Von Hoff, D. D.
European Journal of Cancer (2013)

Fulltext@MSK | Save

A validated prognostic model for predicting overall survival in patients with metastatic chemotherapy naive castrate-resistant prostate cancer

Meeting Abstract

Halabi, S.; Lin, C. Y.; Kelly, W. K.; Fizazi, K.; Moul, J. W.; Kaplan, E.; Morris, M. J.; Small, E. J.
European Journal of Cancer (2013)

Fulltext@MSK | Save

Treatment sequencing following first-line sunitinib in patients (pts) with advanced renal cell carcinoma (RCC)

Meeting Abstract

Gore, M. E.; Hutson, T. E.; Lin, X.; Korytowsky, B.; Lechuga, M. J.; Matczak, E.; Figlin, R. A.; Bukowski, R.; Motzer, R. J.
European Journal of Cancer (2013)

Fulltext@MSK | Save